Periodic Reporting for period 1 - EMPATIC (Engineered multi-well platforms integrating biochemical and biophysical cues for the functional maturation and electrophysiological monitoring of cardiac tissue models.)
Okres sprawozdawczy: 2024-07-01 do 2025-12-31
Cardiovascular diseases continue to represent a major global health burden, highlighting the urgent need for more effective and safer therapeutic strategies. A critical limitation in current biomedical research lies in the insufficient predictive power of traditional preclinical models, which often fail to replicate the structural, mechanical, and functional complexity of human cardiac tissue. Advances in bioengineering have demonstrated the potential of three-dimensional (3D) in vitro cardiac models to better reproduce key aspects of human heart physiology, offering new opportunities for more reliable translational research.
Building on recent progress in cardiac tissue engineering, EMPATIC project developed an innovative platform designed to support the generation of physiologically relevant human cardiac tissue in vitro. The system combines advanced culture environment with integrated functional monitoring capabilities. This approach enables controlled cellular organization and functional assessment in a scalable and user-friendly configuration, facilitating broader adoption in research and preclinical settings.
By contributing to the development of more human-relevant in vitro cardiac models, EMPATIC supports the advancement of New Approach Methodologies (NAMs) and promotes a transition toward more predictive, ethical, and sustainable biomedical research practices. In the long term, the platform has the potential to enhance drug development efficiency, improve safety evaluation, and reduce reliance on animal experimentation, ultimately accelerating innovation in cardiovascular and regenerative medicine.